Your cart is empty.
Männedorf, Switzerland, March 5, 2013 – BioSentinel has selected Tecan’s Infinite® F500 as the reader of choice for its high sensitivity botulinum neurotoxin (BoNT) assays. Dr Ward Tucker, Director of Research and Development at BioSentinel, explained: “Our fluorescencebased BoTest® and BoCell® assays were developed using a high end, monochromator-based reader; however, we needed a more cost-effective solution that we could recommend to customers who did not already have fluorescence detection capabilities.”
“The Infinite F500 was clearly the best match for our needs. Its standard filter sets are well suited to our assays, and it offers us the flexibility to optimize the number and location of reads within the well. Automated Zoptimization ensures that the maximum signal intensity is achieved, further improving the sensitivity of our assays at low BoNT concentrations. The quality of the data achieved using the Infinite F500 was therefore superior to competitor instruments for our assay kits. Combined with Tecan’s excellent reputation and the fact that several other molecular diagnostic companies recommend Tecan readers, this made the Infinite F500 the logical choice. Since purchasing our instrument it has been in daily use by multiple users, and has proven both straightforward and reliable to operate; we’ve not had any issues in terms of functionality and it always performs exactly as we expect.”
To find out more about Tecan’s Infinite F500, visit www.tecan.com/infinitef500
For more information please contact
Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).